Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2018-05-10 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
FURTHER DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding a further delay in the despatch of a circular related to a major transaction (subscription of shares). It references previous announcements and states that additional time is required to prepare and finalize information for the circular. The document is short (2058 characters) and does not contain financial statements or detailed financial data. It is an announcement about the timing of a report (the circular), not the report itself. Therefore, it fits the category of Report Publication Announcement (RPA).
2018-05-10 English
DISCLOSURE PURSUANT TO RULES 13.13 AND 13.14 OF THE LISTING RULES
Capital/Financing Update Classification · 95% confidence The document is an announcement made pursuant to specific rules (Rules 13.13 and 13.14) of the Hong Kong Listing Rules. It details the entering into of a Facility Agreement for margin loan facilities by a subsidiary of the company. The content focuses on the terms of the loan, the parties involved, the purpose, and regulatory implications under the Listing Rules. It is not a financial report, earnings release, or management discussion but a regulatory disclosure about a financing arrangement. The document is lengthy (over 10,000 characters) and contains detailed information about the financing facility, which aligns with a Capital/Financing Update. It is not a report publication announcement or a regulatory filing of a different nature. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-05-10 English
DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION FOR NOTES
Capital/Financing Update Classification · 95% confidence The document is an announcement by CMBC Capital Holdings Limited regarding a discloseable transaction related to the subscription for notes amounting to US$30,000,000. It references the Listing Rules of the Hong Kong Stock Exchange, specifically Chapter 14, which governs discloseable transactions. The content details the terms of the notes, parties involved, financial covenants, and implications under the Listing Rules. There is no presentation of financial statements or detailed financial performance data, nor is it a transcript, management report, or audit report. The document is clearly an announcement about a capital market transaction (subscription for notes) and the related regulatory disclosure requirements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is over 10,000 characters and contains substantive details about the financing transaction, supporting a high confidence classification.
2018-05-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2018
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on authorized and issued share capital, share options, warrants, convertibles, and other share-related movements for the month ended 30/04/2018. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes detailed tables of share capital changes, share options, and other equity-related information. There is no indication that this is an announcement of a report publication or a brief summary; rather, it is a regulatory filing providing detailed share capital movement data. This type of document fits best under the category of Share Issue/Capital Change (SHA), as it reports on changes in share capital and related securities movements.
2018-05-02 English
VOLUNTARY ANNOUNCEMENT - FINANCIAL ASSISTANCE FROM CONTROLLING SHAREHOLDER
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CMBC Capital Holdings Limited regarding an increase in financial assistance from its controlling shareholder. It details the terms of a supplemental facility letter increasing the maximum principal amount of facilities. The document is relatively short (3048 characters) and focuses on a financing update rather than a full financial report. It does not contain financial statements or detailed financial analysis but rather an update on financing arrangements. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-05-02 English
Annual Report 2017
Regulatory Filings
2018-04-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.